发布求助
文献互助 智能选刊 最新文献

Best Practice & Research Clinical Gastroenterology最新文献

筛选
英文 中文
Copyright Information 版权信息
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/S1521-6918(24)00092-1
{"title":"Copyright Information","authors":"","doi":"10.1016/S1521-6918(24)00092-1","DOIUrl":"10.1016/S1521-6918(24)00092-1","url":null,"abstract":"","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101967"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143165756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial dysbiosis in gastric cancer: Association or causation? 胃癌微生物生态失调：关联还是原因？
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101961
Pallavi Huma Arya, Bhamini Vadhwana, Munir Tarazi
{"title":"Microbial dysbiosis in gastric cancer: Association or causation?","authors":"Pallavi Huma Arya, Bhamini Vadhwana, Munir Tarazi","doi":"10.1016/j.bpg.2024.101961","DOIUrl":"10.1016/j.bpg.2024.101961","url":null,"abstract":"","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101961"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis 微生物组在免疫检查点抑制剂结肠炎和肝炎中的作用
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101945
Thomas Ryan , Sophia Ling , Andrew Trinh , Jonathan P. Segal
{"title":"The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis","authors":"Thomas Ryan ,&nbsp;Sophia Ling ,&nbsp;Andrew Trinh ,&nbsp;Jonathan P. Segal","doi":"10.1016/j.bpg.2024.101945","DOIUrl":"10.1016/j.bpg.2024.101945","url":null,"abstract":"<div><div>Immune checkpoint inhibitors have revolutionised management for a variety of different types of malignancies. However, gastrointestinal adverse effects, in particular colitis and hepatitis, are relatively common with up to 30 % of patients being affected. The gut microbiome has emerged as a potential contributor to both the effectiveness of immune checkpoint inhibitors and their side effects. This review will attempt to examine the impact the microbiome has on adverse effects as a result of immune checkpoint inhibitors as well as the potential for manipulation of the microbiome as a form of management for immune mediated colitis.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101945"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142186346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiota in colorectal cancer: From pathogenesis to clinic 大肠癌中的肠道微生物群：从发病机制到临床
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101941
William Fusco , Ludovica Bricca , Francesco Kaitsas , Maria Francesca Tartaglia , Irene Venturini , Massimo Rugge , Antonio Gasbarrini , Giovanni Cammarota , Gianluca Ianiro
{"title":"Gut microbiota in colorectal cancer: From pathogenesis to clinic","authors":"William Fusco ,&nbsp;Ludovica Bricca ,&nbsp;Francesco Kaitsas ,&nbsp;Maria Francesca Tartaglia ,&nbsp;Irene Venturini ,&nbsp;Massimo Rugge ,&nbsp;Antonio Gasbarrini ,&nbsp;Giovanni Cammarota ,&nbsp;Gianluca Ianiro","doi":"10.1016/j.bpg.2024.101941","DOIUrl":"10.1016/j.bpg.2024.101941","url":null,"abstract":"<div><div>Colorectal cancer is the third most common type of cancer, with a significant burden on healthcare and social systems. Its incidence is constantly rising, due to the spread of unhealthy lifestyle, i.e. Western diet. Increasing evidence suggests that westernization-driven microbiome alterations may play a critical role in colorectal tumorigenesis. The current screening strategies for this neoplasm, mainly fecal immunochemical tests, are burdened by unsatisfactory accuracy. Novel, non-invasive biomarkers are rising as the new frontier of colorectal cancer screening, and the microbiome-based ones are showing positive and optimistic results. This Review describes our current knowledge on the role of gut microbiota in colorectal cancer, from its pathogenetic action to its clinical potential as diagnostic biomarker.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101941"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141945574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders 西方饮食对非传染性慢性疾病发展的微生物影响
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101923
Andrea Severino , Ege Tohumcu , Luca Tamai , Pasquale Dargenio , Serena Porcari , Debora Rondinella , Irene Venturini , Marcello Maida , Antonio Gasbarrini , Giovanni Cammarota , Gianluca Ianiro
{"title":"The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders","authors":"Andrea Severino ,&nbsp;Ege Tohumcu ,&nbsp;Luca Tamai ,&nbsp;Pasquale Dargenio ,&nbsp;Serena Porcari ,&nbsp;Debora Rondinella ,&nbsp;Irene Venturini ,&nbsp;Marcello Maida ,&nbsp;Antonio Gasbarrini ,&nbsp;Giovanni Cammarota ,&nbsp;Gianluca Ianiro","doi":"10.1016/j.bpg.2024.101923","DOIUrl":"10.1016/j.bpg.2024.101923","url":null,"abstract":"<div><div>Noncommunicable chronic disorders (NCDs) are multifactorial disorders that share a state of chronic, low-grade inflammation together with an imbalance of gut microbiota. NCDs are becoming increasingly prevalent worldwide, and mainly in Western countries, with a significant impact on global health.</div><div>Societal changes, together with the widespread diffusion of modern agricultural methods and food processing, have led to a significant shift in dietary habits over the past century, with an increased diffusion of the Western diet (WD). WD includes foods high in saturated fat, refined sugars, salt, sweeteners, and low in fiber, and is characterized by overeating, frequent snacking, and a prolonged postprandial state.</div><div>An increasing body of evidence supports the association between the diffusion of WD and the rising prevalence of NCDs. WD also negatively affects both gut microbiota and the immune system by driving to microbial alterations, gut barrier dysfunction, increased intestinal permeability, and leakage of harmful bacterial metabolites into the bloodstream, with consequent contribution to the development of systemic low-grade inflammation. In this review article we aim to dissect the role of gut microbiota imbalance and gut barrier impairment in mediating the detrimental effects of WD on the development of NCDs, and to identify potential therapeutic strategies.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101923"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141031346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy 肠道微生物组在调节免疫检查点抑制剂疗法反应中的作用
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101944
Nathan J. Dean , Paolo D. d’Arienzo , Hajir Ibraheim , Karla A. Lee , Anna C. Olsson-Brown , David J. Pinato , Nicholas Powell
{"title":"The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy","authors":"Nathan J. Dean ,&nbsp;Paolo D. d’Arienzo ,&nbsp;Hajir Ibraheim ,&nbsp;Karla A. Lee ,&nbsp;Anna C. Olsson-Brown ,&nbsp;David J. Pinato ,&nbsp;Nicholas Powell","doi":"10.1016/j.bpg.2024.101944","DOIUrl":"10.1016/j.bpg.2024.101944","url":null,"abstract":"<div><div>Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy, yet the proportion of patients who achieve long-term disease control remain suboptimal. Over the past decade, the gut microbiome has been shown to influence immune-mediated tumour suppression as well as responses to ICI therapies. Compositional differences in gut microbiome may account for the differences in outcomes from immune checkpoint blockade. Identifying microbiota species associated with favourable/unfavourable outcomes and modelling their dynamics throughout the course of ICI treatment could help develop predictive biomarkers of immunotherapy response, and manipulating the gut microbiome represent a novel approach to enhancing ICI effectiveness. Clinically, this raises the prospect of using gut microbiome-based therapies to overcome primary resistance to ICIs, mitigate the effects of microbiome-altering drugs such as antibiotics or proton pump inhibitors, and improve overall survival in patients across numerous different cancer types.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101944"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142186347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians 炎症和结直肠癌中的肠道微生物群：临床医生的潜在工具箱
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101942
Nathan Grellier , Andrea Severino , Sebastiano Archilei , Jumin Kim , Antonio Gasbarrini , Giovanni Cammarota , Serena Porcari , Nicolas Benech
{"title":"Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians","authors":"Nathan Grellier ,&nbsp;Andrea Severino ,&nbsp;Sebastiano Archilei ,&nbsp;Jumin Kim ,&nbsp;Antonio Gasbarrini ,&nbsp;Giovanni Cammarota ,&nbsp;Serena Porcari ,&nbsp;Nicolas Benech","doi":"10.1016/j.bpg.2024.101942","DOIUrl":"10.1016/j.bpg.2024.101942","url":null,"abstract":"<div><div>Colorectal cancer (CRC) is a worldwide public health issue specifically in patients with chronic diseases associated with a western lifestyle, such as metabolic diseases and inflammatory bowel diseases (IBD). Interestingly, both metabolic disorders and IBD are characterized by a chronic state of inflammation that contributes to the carcinogenesis with specific alteration of the gut microbiota composition and function. Evidence now shows that this altered gut microbiota contributes fueling a chronic pro-inflammatory state in a vicious circle that can favor CRC development. In this review article, we present the current knowledge concerning the involvement of the gut microbiota as a procarcinogenic factor shared by IBD and cardiometabolic diseases, and provide clues as to how it may be used to prevent or diagnose CRC.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101942"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141945573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma 免疫微环境对食管癌预后的影响。
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-09-01 DOI: 10.1016/j.bpg.2024.101954
Dimitra V. Peristeri , Munir Tarazi , Patrick Casey , Arfon Powell , Javed Sultan
{"title":"Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma","authors":"Dimitra V. Peristeri ,&nbsp;Munir Tarazi ,&nbsp;Patrick Casey ,&nbsp;Arfon Powell ,&nbsp;Javed Sultan","doi":"10.1016/j.bpg.2024.101954","DOIUrl":"10.1016/j.bpg.2024.101954","url":null,"abstract":"<div><div>Oesophageal adenocarcinoma (OAC) is amongst the most lethal cancers worldwide, with poor treatment response leading to low survival rates. Recent improvements have been achieved by including the tumour microenvironment (TME) and patients' immune profiles in treatment decisions. We already know that patients with immune-enriched/inflamed TME have better survival outcomes. However, OAC TME is largely immunosuppressed and appears to be treatment-resistant. Immunotherapeutic strategies are already part of the therapeutic plans in OAC; a greater understanding of the immune microenvironment underlying oesophageal adenocarcinoma is needed if we are to exploit the inherent cancer-fighting capabilities of each patient's immune system. Therefore, implementing the crosstalks between the tumour and its microenvironment (TME) might be the key to improving overall survival. In this review, we discuss accumulated evidence regarding TME and immune checkpoint inhibitors in OAC, as well as recent and ongoing therapeutic attempts to improve patient treatment and outcomes at an individual level.</div></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"72 ","pages":"Article 101954"},"PeriodicalIF":3.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Per oral endoscopic myotomy for achalasia 治疗贲门失弛缓症的经口腔内窥镜肌切开术
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101930
{"title":"Per oral endoscopic myotomy for achalasia","authors":"","doi":"10.1016/j.bpg.2024.101930","DOIUrl":"10.1016/j.bpg.2024.101930","url":null,"abstract":"<div><p><span><span><span>Achalasia, characterized by impaired lower esophageal sphincter (LES) relaxation and failed </span>peristalsis<span>, stands out as the most widely recognized primary esophageal motility disorder. It manifests with </span></span>dysphagia<span> to solid and liquid foods, chest pain<span>, regurgitation, and weight loss, leading to significant morbidity and healthcare burden. Traditionally, surgical Heller myotomy<span> and pneumatic dilation were the primary therapeutic approaches for achalasia. However, in 2009, Inoue and colleagues introduced a groundbreaking endoscopic technique called peroral endoscopic myotomy (POEM), revolutionizing the management of this condition. This review aims to comprehensively examine the recent advancements in the POEM technique for patients diagnosed with achalasia, delving into critical aspects, such as the tailoring of the myotomy, the prevention of intraprocedural adverse events (AEs), the evaluation of long-term outcomes, and the feasibility of </span></span></span></span>retreatment in cases of therapeutic failure.</p></div>","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101930"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141395233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perface to special edition: Third space endoscopy 特刊序言：第三空间内窥镜
IF 3.2 3区 医学
Best Practice & Research Clinical Gastroenterology Pub Date : 2024-08-01 DOI: 10.1016/j.bpg.2024.101940
Jan Martinek
{"title":"Perface to special edition: Third space endoscopy","authors":"Jan Martinek","doi":"10.1016/j.bpg.2024.101940","DOIUrl":"10.1016/j.bpg.2024.101940","url":null,"abstract":"","PeriodicalId":56031,"journal":{"name":"Best Practice & Research Clinical Gastroenterology","volume":"71 ","pages":"Article 101940"},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141785964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信